Search Results - "RICKARD, K"

Refine Results
  1. 1

    A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy by Ferguson, Gary T, Kerwin, Edward M, Rheault, Tara, Bengtsson, Thomas, Rickard, Kathleen

    “…Ensifentrine is an inhaled dual inhibitor of phosphodiesterase (PDE) 3 and 4 that has shown bronchodilatory effects and symptom improvement in clinical studies…”
    Get full text
    Journal Article
  2. 2

    Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis by Watz, Henrik, Rickard, Kathleen, Rheault, Tara, Bengtsson, Thomas, Singh, Dave

    “…Ensifentrine is an inhaled first-in-class dual inhibitor of phosphodiesterase (PDE) 3 and 4. In a four-week randomized, double-blind, placebo-controlled,…”
    Get full text
    Journal Article
  3. 3

    Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study by Donohue, James F, Herje, Nancy, Crater, Glenn, Rickard, Kathleen

    “…To characterize fractional exhaled nitric oxide (FeNO) levels that may be indicative of Th2-mediated airway inflammation in patients with chronic obstructive…”
    Get full text
    Journal Article
  4. 4

    Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis by Bernstein, D.I., Levy, A.L., Hampel, F.C., Baidoo, C.A., Cook, C.K., Philpot, E.E., Rickard, K.A.

    Published in Clinical and experimental allergy (01-06-2004)
    “…Summary Background If monotherapy with an intranasal corticosteroid can alleviate both nasal and ocular symptoms of allergic rhinitis, treatment may be…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Environmental and Societal Factors Affect Food Choice and Physical Activity: Rationale, Influences, and Leverage Points by Booth, Sarah L., Sallis, James F., Ritenbaugh, Cheryl, Hill, James O., Birch, Leann L., Frank, Lawrence D., Glanz, Karen, Himmelgreen, David A., Mudd, Michael, Popkin, Barry M., Rickard, Karyl A., Jeor, Sachiko St, Hays, Nicholas P.

    Published in Nutrition reviews (01-03-2001)
    “…Dietary and physical activity behaviors that affect health are influenced by a wide variety of forces. It is important to appreciate the interaction among…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Efficacy of salmeterol xinafoate in the treatment of COPD by Mahler, D A, Donohue, J F, Barbee, R A, Goldman, M D, Gross, N J, Wisniewski, M E, Yancey, S W, Zakes, B A, Rickard, K A, Anderson, W H

    Published in Chest (01-04-1999)
    “…To examine and compare the efficacy and safety of salmeterol xinafoate, a long-acting inhaled beta2-adrenergic agonist, with inhaled ipratropium bromide and…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma by Busse, William, Nelson, Harold, Wolfe, James, Kalberg, Christopher, Yancey, Steven W., Rickard, Kathleen A.

    Published in Journal of allergy and clinical immunology (01-06-1999)
    “…Background: Salmeterol, a long-acting β 2 -agonist, and zafirlukast, a leukotriene receptor antagonist, are both indicated for the treatment of asthma in…”
    Get full text
    Journal Article
  11. 11

    Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma by Bleecker, Eugene R., Welch, Michael J., Weinstein, Steven F., Kalberg, Christopher, Johnson, Marty, Edwards, Lisa, Rickard, Kathleen A.

    Published in Journal of allergy and clinical immunology (01-06-2000)
    “…Background: Few studies have compared the efficacy of inhaled corticosteroids and leukotriene modifiers for the treatment of persistent asthma. Objective: Our…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cardiac surgery and catheterization in patients with Haemophilia by MacKinlay, N, Taper, J, Renisson, F, Rickard, K

    “…The present study summarizes the results of 12 cardiac surgical procedures performed in a carrier of Haemophilia B and in six patients with Haemophilia A at a…”
    Get full text
    Journal Article
  14. 14

    Modern treatment of haemophilia by BERNTORP, E, BOULYJENKOV, V, SEREMETIS, S, BRETTLER, D, CHANDY, M, JONES, P, LEE, C, LUSHER, J, MANNUCCI, P, PEAK, I, RICKARD, K

    Published in Bulletin of the World Health Organization (01-09-1995)
    “…Many rapid advances have been made in the diagnosis and therapy of haemophilia. Nevertheless, the condition still poses problems and challenges (e.g., joint…”
    Get full text
    Journal Article
  15. 15

    The Low Risk of Hepatitis C Virus Transmission Among Sexual Partners of Hepatitis C-Infected Hemophilic Males: An International, Multicenter Study by Brettler, D.B., Mannucci, P.M., Gringeri, A., Rasko, J.E., Forsberg, A.D., Rumi, M.G., Garsia, R.J., Rickard, K.A., Colombo, M.

    Published in Blood (15-07-1992)
    “…To study the transmission rate of hepatitis C virus (HCV) in the female sexual partners of antibody-positive hemophilic males, 106 partners from three…”
    Get full text
    Journal Article
  16. 16

    Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro by Rickard, Kurt L., Gibson, Peter R., Young, Graeme P., Phillips, Wayne A.

    Published in Carcinogenesis (New York) (01-06-1999)
    “…As the colonic epithelium is physiologically exposed to butyrate and to activators of protein kinase C, we examined the effect of the protein kinase C…”
    Get full text
    Journal Article
  17. 17

    Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy by Fish, J E, Israel, E, Murray, J J, Emmett, A, Boone, R, Yancey, S W, Rickard, K A

    Published in Chest (01-08-2001)
    “…Comparison of inhaled salmeterol powder vs oral montelukast treatment in patients with persistent asthma who remained symptomatic while receiving inhaled…”
    Get more information
    Journal Article
  18. 18

    Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness by Rosenthal, R R, Busse, W W, Kemp, J P, Baker, J W, Kalberg, C, Emmett, A, Rickard, K A

    Published in Chest (01-09-1999)
    “…To determine the effect of long-term salmeterol aerosol therapy on airway hyperresponsiveness measured by methacholine challenge. Randomized, double-blind,…”
    Get more information
    Journal Article
  19. 19

    Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma by Baraniuk, J, Murray, J J, Nathan, R A, Berger, W E, Johnson, M, Edwards, L D, Srebro, S, Rickard, K A

    Published in Chest (01-09-1999)
    “…To compare the efficacies of medium-dose fluticasone propionate (FP), medium-dose triamcinolone acetonide (TAA), and combined low-dose FP plus salmeterol (SL)…”
    Get more information
    Journal Article
  20. 20

    Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma by SHETH, Ketan, BORKER, Rohit, EMMETT, Amanda, RICKARD, Kathleen, DORINSKY, Paul

    Published in PharmacoEconomics (2002)
    “…To compare the relative cost effectiveness of salmeterol (50 microg)/ fluticasone propionate (100 microg) with that of oral montelukast (10mg) as initial…”
    Get full text
    Journal Article